RE: RIP Cizzle25 Mar 2025 20:55
Hermit,
Thanks for your reasonable response; much welcomed.
I think there is a fair chance of what you saying being correct..
Maybe new FDA restrictions are making it harder to get to market, reimbursement code situation, and a multitude of other potential delays.
However, as Joey correctly stated - but most of you have blocked him - it was only January when the CEO stated "launch on track for April".
If you care to go back in time, this type of delay and obfuscation has been the perennial problem with this company.
There is no doubt at all that Ciz will have known that April was not on the cards.
There are many reasons for the delays that you have stated - some of the others that you haven't stated are: 1) there has not been the take up as expected from the healthcare system
2) Ciz bio US is ploughing on with a complement of tests other than lung.
My problem with shareholders here is that every time Cizzle Lie/delay/ confuse.. they just take it laying down, and not as an indicator that the investment is unsafe.
My best guess with this is that CizBio US are driving on with a palette of tests, and Ciz UK will be subsumed in this, as it becomes more and more irrelevant as an entity.
This could be lucrative for Ciz UK holders , or shafted through privatisation, delisting.
Personally I think shareholders here will be shafted, and, let's face it, the share price at the moment isn't leaving anyone smiling.
Got a feeling with the MO of this company that there will be a few shocks to the negative this year..
And let's face it those revenue projections you can push them one more year down the line.
As Green said, ultimately , time will be the judge.